Tissue microarrays: a powerful tool for high-throughput analysis of clinical specimens: a review of the method with validation data.

Tissue microarrays: a powerful tool for high-throughput analysis of clinical specimens: a review of the method with validation data.

Item
http://www.wikidata.org/entity/Q30679607
Recent developments in multiplexing techniques for immunohistochemistry.Differential response of immunohistochemically defined breast cancer subtypes to anthracycline-based adjuvant chemotherapy with or without paclitaxelMMP9 but Not EGFR, MET, ERCC1, P16, and P-53 Is Associated with Response to Concomitant Radiotherapy, Cetuximab, and Weekly Cisplatin in Patients with Locally Advanced Head and Neck Cancer.Evaluation of the prognostic role of centromere 17 gain and HER2/topoisomerase II alpha gene status and protein expression in patients with breast cancer treated with anthracycline-containing adjuvant chemotherapy: pooled analysis of two Hellenic CoEvaluation of the prognostic significance of HER family mRNA expression in high-risk early breast cancer: a Hellenic Cooperative Oncology Group (HeCOG) validation study.HER2 and TOP2A in high-risk early breast cancer patients treated with adjuvant epirubicin-based dose-dense sequential chemotherapy.Comparison of the Ability of Different Clinical Treatment Scores to Estimate Prognosis in High-Risk Early Breast Cancer Patients: A Hellenic Cooperative Oncology Group StudyExpression of MMP-2, -7, -9, MT1-MMP and TIMP-1 and -2 has no prognostic relevance in patients with advanced epithelial ovarian cancer.Epidermal growth factor receptor protein expression and gene amplification in normal, hyperplastic, and cancerous glottic tissue: immunohistochemical and fluorescent in situ hybridization study on tissue microarrays.Tissue Microarray: A rapidly evolving diagnostic and research tool.Association of osteopontin with specific prognostic factors and survival in adjuvant breast cancer trials of the Hellenic Cooperative Oncology Group.Evaluation of the Prognostic Value of RANK, OPG, and RANKL mRNA Expression in Early Breast Cancer Patients Treated with Anthracycline-Based Adjuvant Chemotherapy.Identification of New Players in Hepatocarcinogenesis: Limits and Opportunities of Using Tissue Microarray (TMA).Activation of Stat3 in renal tumors.Trefoil factor 3 overexpression in prostatic carcinoma: prognostic importance using tissue microarrays.Evaluation of the prognostic value of CD3, CD8, and FOXP3 mRNA expression in early-stage breast cancer patients treated with anthracycline-based adjuvant chemotherapy
P2860

Tissue microarrays: a powerful tool for high-throughput analysis of clinical specimens: a review of the method with validation data.

Item
http://www.wikidata.org/entity/Q30679607
description
2002 nî lūn-bûn
@nan
2002 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մարտին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Tissue microarrays: a powerful ...... e method with validation data.
@ast
Tissue microarrays: a powerful ...... e method with validation data.
@en
type
label
Tissue microarrays: a powerful ...... e method with validation data.
@ast
Tissue microarrays: a powerful ...... e method with validation data.
@en
prefLabel
Tissue microarrays: a powerful ...... e method with validation data.
@ast
Tissue microarrays: a powerful ...... e method with validation data.
@en
P1433
P1476
P2093
P304
P31
P356
P433
P478
P577
P698
P356
P1433
P1476
Tissue microarrays: a powerful ...... he method with validation data
@en
P2093
P304
P31
P356
10.1097/00129039-200203000-00001
P433
P478
P577
P698